Endotoxin, the airway transcriptome, and obstructive lung disease

内毒素、气道转录组和阻塞性肺病

基本信息

  • 批准号:
    8617465
  • 负责人:
  • 金额:
    $ 15.34万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-23 至 2018-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Research Asthma and chronic obstructive pulmonary disease (COPD) are chronic inflammatory lung diseases that affect an estimated 35 million Americans. Endotoxin is derived from gram negative bacteria, and has been associated with both asthma and COPD. Endotoxin is almost universally present, and has been found at high levels in tobacco smoke, homes burning biomass fuel, in the context of various occupations especially cotton textile work, and more recently as part of indoor air pollution in schools. We do not fully understand how endotoxin can lead to development or worsening of asthma and COPD. Recent technologic advances have allowed one to simultaneously identify changes in expression of over 14K genes using microarrays. Studies comparing gene expression changes from invasive samples taken from the bronchi (lower airways) and non- invasive samples from the nose (upper airways) have shown many similarities. Studying how endotoxin affects the airways using gene expression changes is an important opportunity to further understand the relationship between endotoxin and lung disease. In this career development proposal, the applicant hypothesizes that endotoxin leads to distinct gene expression changes in the airways. These gene expression changes reflect underlying dysregulated pathways in lung disease that can serve as a biomarker for susceptibility to disease exacerbation, disease development, or clinically important subtypes of lung disease. She proposes to examine the impact of current high endotoxin exposure on airway gene expression in a cohort of inner-city elementary school children with and without asthma. She then proposes to evaluate whether prior endotoxin exposure leads to persistent changes in airway gene expression, even after years of exposure cessation, in a cohort of textile workers. Finally, she proposes to evaluate whether these gene expression changes are markers for important disease-specific subphenotypes, specifically "exacerbation prone" asthmatics in the school study and "emphysema type" COPD in the textile study. These studies take advantage of the sound study infrastructure present in two already existing and unique cohort studies, and will provide novel insights into the ways nasal gene expression can be used to understand the effects of chronic endotoxin exposure in a field setting. The successful completion of this research will help us understand the genes and biological pathways that are affected by chronic high endotoxin exposure, identify people who are susceptible to endotoxin-related asthma exacerbations, determine whether the type of COPD (emphysema vs. airways disease) can be identified using a simple gene expression based test, and may lead the way to the development of new therapies for endotoxin related lung disease. Additionally, it further characterizes the importance of school endotoxin exposure in asthma morbidity, and may shift the focus from home to school environmental controls for children with asthma. Candidate The applicant's long-term career goal is to become an independent clinical/translational NIH funded investigator focused on patient-oriented research in environmental lung disease. In order to achieve this goal, her short-term career objectives are to obtain further didactic training in environmental epidemiology, advanced biostatistics, genomics, and data mining, as well as practical skills in building a cohort, exposure assessment, obtaining biospecimens, nucleic extraction, selection of appropriate microarray technology, and analytic work in interpreting the output. This will be accomplished with formal classes that complement the candidate's prior coursework in completing a Master of Public Health, fieldwork and collaborative work to learn how to measure environmental endotoxin exposure and to recruit, consent, and maintain a cohort, benchwork using molecular methods, attendance at institutional and national conferences, and guidance from established mentors and a multidisciplinary advisory board with the relevant expertise. This will result in a unique combination of practical skills and scientific knowledge that will help her achieve independence from her mentorship team and prepare her to achieve her long-term career goal. Environment The applicant will perform her research training and career development activities at world-renowned major academic institutions. The division in which she will work is one that has a collaborative environment with both a rich research environment and an intense clinical focus, and has an outstanding history of mentorship, leadership in pulmonary and critical care medicine, and clinical excellence. Her institution is very invested in the applicant's successful career development, and will make available all the facilities, resources, and equipment needed for her career development and proposed research. Her mentors are nationally and internationally renowned experts in pediatric asthma and environmental and molecular epidemiology, and will provide full access to the resources accompanying two unique cohorts of endotoxin exposed children and adults.
描述(由申请人提供): 研究哮喘和慢性阻塞性肺病(COPD)是影响约3500万美国人的慢性炎症性肺病。内毒素来源于革兰氏阴性细菌,并且与哮喘和COPD两者相关。内毒素几乎普遍存在,并且在烟草烟雾、燃烧生物质燃料的家庭、各种职业特别是棉纺织工作的背景下,以及最近作为学校室内空气污染的一部分,都发现了高水平的内毒素。我们不完全了解内毒素如何导致哮喘和COPD的发展或恶化。最近的技术进步允许人们使用微阵列同时识别超过14 K个基因表达的变化。比较从支气管(下气道)获取的侵入性样本和从鼻子(上气道)获取的非侵入性样本的基因表达变化的研究显示了许多相似之处。利用基因表达变化研究内毒素如何影响气道是进一步了解内毒素与肺部疾病关系的重要机会。在这份职业发展计划书中,申请人假设内毒素导致气道中不同的基因表达变化。这些基因表达变化反映了肺部疾病中潜在的失调途径,可以作为疾病加重、疾病发展或临床重要的肺部疾病亚型易感性的生物标志物。她建议在一组有哮喘和无哮喘的市中心小学儿童中研究目前高内毒素暴露对气道基因表达的影响。然后,她建议评估是否以前的内毒素暴露导致气道基因表达的持续变化,即使在多年的暴露停止后,在一个队列的纺织工人。最后,她建议评估这些基因表达变化是否是重要疾病特异性亚表型的标志物,特别是学校研究中的“易加重”哮喘患者和纺织品研究中的“肺气肿型”COPD。这些研究利用了两项现有的独特队列研究中存在的良好研究基础设施,并将为鼻基因表达的方式提供新的见解,以了解长期内毒素暴露在野外环境中的影响。这项研究的成功完成将帮助我们了解受慢性高内毒素暴露影响的基因和生物学途径,识别易受内毒素相关哮喘急性发作影响的人群,确定是否可以使用简单的基于基因表达的测试来识别COPD(肺气肿与气道疾病)的类型,并可能导致开发内毒素相关肺部疾病的新疗法。此外,它进一步表征了学校内毒素暴露在哮喘发病率中的重要性,并可能将重点从家庭转移到学校环境控制哮喘儿童。申请人的长期职业目标是成为一名独立的临床/转化NIH资助的研究人员,专注于环境性肺病的患者导向研究。为了实现这一目标,她的短期职业目标是获得环境流行病学,高级生物统计学,基因组学和数据挖掘方面的进一步教学培训,以及建立队列,暴露评估,获得生物标本,核酸提取,选择适当的微阵列技术和解释输出的分析工作的实用技能。这将通过正式课程来完成,这些课程补充了候选人在完成公共卫生硕士学位,实地考察和协作工作方面的先前课程,以学习如何测量环境内毒素暴露并招募,同意和维持一个队列,使用分子方法的基准工作,出席机构和国家会议,以及来自既定导师和具有相关专业知识的多学科咨询委员会的指导。这将导致实践技能和科学知识的独特结合,这将帮助她实现独立于她的导师团队,并为她实现长期职业目标做好准备。环境申请人将在世界知名的主要学术机构进行研究培训和职业发展活动。她将工作的部门是一个具有丰富的研究环境和强烈的临床重点的协作环境,并具有杰出的指导历史,在肺部和重症监护医学方面的领导地位,以及临床卓越。她的机构是非常投资于申请人的成功的职业发展,并将提供所有的设施,资源和设备需要她的职业发展和拟议的研究。她的导师是国内和国际知名的专家在小儿哮喘和环境和分子流行病学,并将提供充分的资源,伴随着两个独特的队列内毒素暴露的儿童和成人。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peggy Sue Lai其他文献

Peggy Sue Lai的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peggy Sue Lai', 18)}}的其他基金

Molecular epidemiology of respiratory virus exposure in elementary schools
小学呼吸道病毒暴露的分子流行病学
  • 批准号:
    10646577
  • 财政年份:
    2023
  • 资助金额:
    $ 15.34万
  • 项目类别:
High efficiency particulate air cleaner intervention to reduce respiratory virus exposure in elementary schools
高效颗粒空气净化器干预减少小学呼吸道病毒暴露
  • 批准号:
    10722583
  • 财政年份:
    2023
  • 资助金额:
    $ 15.34万
  • 项目类别:
The school microbiome and asthma morbidity in inner-city children
内城区儿童的学校微生物组和哮喘发病率
  • 批准号:
    10065492
  • 财政年份:
    2019
  • 资助金额:
    $ 15.34万
  • 项目类别:
The school microbiome and asthma morbidity in inner-city children
内城区儿童的学校微生物组和哮喘发病率
  • 批准号:
    10541838
  • 财政年份:
    2019
  • 资助金额:
    $ 15.34万
  • 项目类别:
The school microbiome and asthma morbidity in inner-city children
内城区儿童的学校微生物组和哮喘发病率
  • 批准号:
    10317083
  • 财政年份:
    2019
  • 资助金额:
    $ 15.34万
  • 项目类别:
Endotoxin, the airway transcriptome, and obstructive lung disease
内毒素、气道转录组和阻塞性肺病
  • 批准号:
    9066670
  • 财政年份:
    2013
  • 资助金额:
    $ 15.34万
  • 项目类别:
Endotoxin, the airway transcriptome, and obstructive lung disease
内毒素、气道转录组和阻塞性肺病
  • 批准号:
    8852128
  • 财政年份:
    2013
  • 资助金额:
    $ 15.34万
  • 项目类别:
Endotoxin, the airway transcriptome, and obstructive lung disease
内毒素、气道转录组和阻塞性肺病
  • 批准号:
    8739644
  • 财政年份:
    2013
  • 资助金额:
    $ 15.34万
  • 项目类别:
Lung disease due to chronic endotoxin exposure in mouse and human models
小鼠和人类模型中慢性内毒素暴露引起的肺部疾病
  • 批准号:
    8608942
  • 财政年份:
    2012
  • 资助金额:
    $ 15.34万
  • 项目类别:
Lung disease due to chronic endotoxin exposure in mouse and human models
小鼠和人类模型中慢性内毒素暴露引起的肺部疾病
  • 批准号:
    8252322
  • 财政年份:
    2012
  • 资助金额:
    $ 15.34万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.34万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 15.34万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.34万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.34万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.34万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.34万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.34万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 15.34万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 15.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 15.34万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了